FuJae Partners advises Veranex on acquisition of Worrell
December 24, 2021
Veranex在2021年12月7日宣布其对Worrell的收购。此项交易的相关协议已于近日签署。
On December 7, 2021, Veranex announced that it entered into a binding agreement to acquire Worrell, a global design firm specializing in healthcare innovation and strategy.
Veranex与Worrell均未披露此次交易的交易价格。在完成通常的交割手续后,整个交易已经在2021年12月份完成交割。
Financial terms of the transaction were not disclosed. The transaction has been closed in December 2021, after finishing customary closing conditions.
“The addition of Worrell strengthens Veranex’s offerings as the leading global provider in the medical device and biotech space.” said Veranex Executive Chairman Patrick Donnelly.
富杰律师事务所,与其战略合作伙伴美阁富律师事务所一起,在本项收购交易中,就涉及中国的公司实体、业务和相关程序,为Veranex提供专业服务。
FuJae Partners, together with its alliance firm McGuireWoods, advised Veranex on this acquisition deal in connection with the China entity and elements of this acquisition transaction.
Back